These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23651030)

  • 21. Cancer pharmacogenomics: strategies and challenges.
    Wheeler HE; Maitland ML; Dolan ME; Cox NJ; Ratain MJ
    Nat Rev Genet; 2013 Jan; 14(1):23-34. PubMed ID: 23183705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.
    Tavakolpour S; Darvishi M; Ghasemiadl M
    Clin Genet; 2018 Mar; 93(3):481-497. PubMed ID: 29194620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. iGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research.
    Chen X; Guo Y; Chen X
    Genomics Proteomics Bioinformatics; 2020 Apr; 18(2):150-160. PubMed ID: 32916316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacogenetics in oncology: the paradigm of molecular targeted therapies.
    Mountzios G; Sanoudou D; Syrigos KN
    Curr Pharm Des; 2010; 16(20):2184-93. PubMed ID: 20459386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of pharmacogenetics on medicine.
    Weber WW
    Environ Mol Mutagen; 2001; 37(3):179-84. PubMed ID: 11317335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The application of next-generation sequencing technologies to drug discovery and development.
    Woollard PM; Mehta NA; Vamathevan JJ; Van Horn S; Bonde BK; Dow DJ
    Drug Discov Today; 2011 Jun; 16(11-12):512-9. PubMed ID: 21440664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic phenotype prediction from genotyping data: a bottleneck for the implementation of pharmacogenetics in drug development and clinical practice.
    LLerena A; Peñas-Lledó EM
    Drug Metab Pers Ther; 2015 Sep; 30(3):143-5. PubMed ID: 26353178
    [No Abstract]   [Full Text] [Related]  

  • 31. Using germline genotype in cancer pharmacogenetic studies.
    McWhinney SR; McLeod HL
    Pharmacogenomics; 2009 Mar; 10(3):489-93. PubMed ID: 19650256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current and potential impact of genetics and genomics on neuropsychopharmacology.
    Harrison PJ
    Eur Neuropsychopharmacol; 2015 May; 25(5):671-81. PubMed ID: 23528807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic pharmacogenomics in cancer.
    Ikediobi ON
    Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice.
    Shahabi P; Dubé MP
    Int J Cardiol; 2015 Apr; 184():772-795. PubMed ID: 25838112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.
    Guchelaar HJ; Gelderblom H; van der Straaten T; Schellens JH; Swen JJ
    Clin Pharmacol Ther; 2014 Apr; 95(4):383-5. PubMed ID: 24448475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translation of pharmacogenetic knowledge into cancer therapeutics.
    Yong WP; Innocenti F
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):698-706. PubMed ID: 17982411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetic testing in the United Kingdom genetics and immunogenetics laboratories.
    Higgs J; Gambhir N; Ramsden SC; Poulton K; Newman WG
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):121-5. PubMed ID: 20039783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in the pharmacogenetics of cancer chemotherapy.
    Watters JW; McLeod HL
    Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics: transforming clinical medicine.
    Newman WG
    J R Coll Physicians Edinb; 2012; 42(3):244-7. PubMed ID: 22953321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.